PMV Pharmaceuticals, Inc. (PMVP) › Operating IncomePMV Pharmaceuticals, Inc. (PMVP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$18.89M2019: -$26.64M2020: -$34.94M2021: -$58.29M2022: -$77.04M2023: -$80.13M2024: -$85.45M2025: -$86.21M-$86.21M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$86.21M-0.9%2024-$85.45M-6.6%2023-$80.13M-4.0%2022-$77.04M-32.2%2021-$58.29M-66.8%2020-$34.94M-31.2%2019-$26.64M-41.0%2018-$18.89M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share